| Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice D Mikus, P Sikiric, S Seiwerth, A Petricevic, G Aralica, N Druzijancic, ... Burns 27 (8), 817-827, 2001 | 129 | 2001 |
| The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes V Dermanovic Dobrota, P Hrabac, D Skegro, R Smiljanic, S Dobrota, ... Health and quality of life outcomes 12, 1-8, 2014 | 125 | 2014 |
| Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system D Balenovic, ML Bencic, M Udovicic, K Simonji, JS Hanzevacki, I Barisic, ... Regulatory peptides 156 (1-3), 83-89, 2009 | 117 | 2009 |
| Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats N Jelovac, P Sikiric, R Rucman, M Petek, A Marovic, D Perovic, ... European journal of pharmacology 379 (1), 19-31, 1999 | 97 | 1999 |
| The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation P Sikiric, J Šeparovic, T Anic, G Buljat, D Mikus, S Seiwerth, Z Grabarevic, ... Journal of Physiology-Paris 93 (6), 479-485, 1999 | 85 | 1999 |
| Urine high sensitive Troponin I measuring in patients with hypertension P Pervan, T Svagusa, I Prkacin, A Savuk, M Bakos, S Perkov Signa Vitae 13 (3), 62-64, 2017 | 81 | 2017 |
| Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ... The Lancet 401 (10388), 1584-1594, 2023 | 79 | 2023 |
| Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol … I Prkacin, J Separovic, G Aralicia, D Perovic, M Gjurasin, M Lovric-Bencic, ... Journal of Physiology-Paris 95 (1-6), 315-324, 2001 | 79 | 2001 |
| Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats. I Prkacin, G Aralica, D Perovic, J Separovic, M Gjurasin, M Lovric-Bencic, ... Journal of Physiology-Paris 95 (1-6), 295-301, 2001 | 65 | 2001 |
| Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and … P Sikiric, S Seiwerth, Z Grabarevic, I Balen, G Aralica, M Gjurasin, ... Journal of Physiology-Paris 95 (1-6), 261-270, 2001 | 56 | 2001 |
| Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157 P Sikiric, J Šeparovic, G Buljat, T Anic, D Stancic-Rokotov, D Mikus, ... Journal of Physiology-Paris 94 (2), 105-110, 2000 | 55 | 2000 |
| Occult gastrointestinal bleeding in rugby player Z Babic, B Papa, M Sikirica-Bosnjakovic, I Prkacin Journal of sports medicine and physical fitness 41 (3), 399, 2001 | 54 | 2001 |
| Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and … I Bilic, I Zoricic, T Anic, J Separovic, D Stancic-Rokotov, D Mikus, G Buljat, ... Life sciences 68 (16), 1905-1912, 2001 | 52 | 2001 |
| Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat P Sikiric, S Seiwerth, G Aralica, D Perovic, M Staresinic, T Anic, ... Journal of Physiology-Paris 95 (1-6), 283-288, 2001 | 51 | 2001 |
| Mortal furosemide-hypokalemia-disturbances in rats NO-system related. Shorten survival by L-NAME. Therapy benefit with BPC 157 more than with L-arginine D Balenovic, I Barisic, I Prkacin, I Horvat, M Udovicic, S Uzun, D Strinic, ... J Clin Exp Cardiolog 3, 201, 2012 | 50 | 2012 |
| Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus. I Prkacin, B Novak, J Sertić, A Mrzljak Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 55 (2 …, 2001 | 50 | 2001 |
| Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances. P Sikiric, N Jelovac, A Jelovac-Gjeldum, G Dodig, M Staresinic, T Anic, ... Acta Pharmacologica Sinica 23 (5), 412-422, 2002 | 44 | 2002 |
| The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants P Sikiric, J Šeparovic, G Buljat, T Anic, D Stancic-Rokotov, D Mikus, ... Journal of Physiology-Paris 94 (2), 99-104, 2000 | 42 | 2000 |
| Prognostic significance of glomerular and tubulointerstitial morphometry in idiopathic membranous nephropathy I Horvatic, DG Ljubanovic, S Bulimbasic, M Knotek, I Prkacin, M Tisljar, ... Pathology-Research and Practice 208 (11), 662-667, 2012 | 35 | 2012 |
| Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial BH Rovin, J Barratt, HJL Heerspink, CE Alpers, S Bieler, DW Chae, ... The Lancet 402 (10417), 2077-2090, 2023 | 31 | 2023 |
